Bonnie L Bassler's Net Worth
$12 Million
Who is Bonnie L Bassler?
Bonnie L Bassler has an estimated net worth of $12 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS, INC., Royalty Pharma plc, Kaleido Biosciences, Inc., and Cidara Therapeutics, Inc..
SEC CIK
Bonnie L Bassler's CIK is 0001683607
Past Insider Trading and Trends
2022 was Bonnie L Bassler's most active year for acquiring shares with 14 total transactions. Bonnie L Bassler's most active month to acquire stocks was the month of May. 2022 was Bonnie L Bassler's most active year for disposing of shares, totalling 12 transactions. Bonnie L Bassler's most active month to dispose stocks was the month of July. 2021 saw Bonnie L Bassler paying a total of $2,614,548.61 for 87,060 shares, this is the most they've acquired in one year. In 2020 Bonnie L Bassler cashed out on 10,236 shares for a total of $3,147,610.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REGENERON PHARMACEUTICALS, INC. (REGN) Snapshot price: $1131.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$770.70 | -$603,741.60 | 1.38K |
Scheduled
|
Aug 15
| ||
Form 4
|
—
|
0
|
$716.70 | -$522,093.60 | 1.38K |
Scheduled
|
Jun 24
| ||
Form 4
|
—
|
0
|
$695.98 | -$521,051.35 | 1.38K |
Scheduled
|
Jun 5
| ||
Form 4
|
—
|
0
|
$685.59 | -$501,579.82 | 1.38K |
Feb 26
| |||
Form 4
|
—
|
0
|
$669.98 | -$478,047.35 | 1.38K |
Scheduled
|
Jan 30
| ||
Form 4
| +10.83% | 135 |
$647.48 | -$440,299.30 | 1.38K |
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
|
—
|
0
|
$623.35 | -$300,919.10 | 1.25K |
Scheduled
|
Dec 13
| ||
Form 4
|
—
|
0
|
$610.46 | -$372,829.24 | 1.25K |
Aug 21
| |||
Form 4
|
—
|
0
|
$590.46 | -$338,709.24 | 1.25K |
Aug 10
| |||
Form 4
|
—
|
0
|
$599.48 | -$541,942.00 | 1.25K |
Mar 24
| |||
Form 4
|
—
|
0
|
$579.98 | -$406,409.05 | 1.25K |
Scheduled
|
Feb 3
| ||
Form 4
| +15.25% | 165 |
—
|
—
| 1.25K |
Jan 3
| |||
Form 4
|
—
|
0
|
$579.98 | -$86,774.90 | 1.08K |
Scheduled
|
Dec 8
| ||
Form 4
|
—
|
0
|
$546.82 | -$999,688.64 | 1.08K |
Scheduled
|
Sep 8 - Sep 9
| ||
Form 4
|
—
|
0
|
$552.98 | -$426,622.00 | 1.08K |
Scheduled
|
Apr 7
| ||
Form 4
|
—
|
0
|
$540.48 | -$395,622.00 | 1.08K |
Scheduled
|
Mar 30
| ||
Form 4
| +21.44% | 191 |
—
|
—
| 1.08K |
Jan 3
| |||
Form 4
|
—
|
0
|
$503.35 | -$308,784.89 | 891 |
Scheduled
|
Aug 16
| ||
Form 4
|
—
|
0
|
$495.96 | -$532,476.72 | 891 |
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
$483.46 | -$468,318.64 | 891 |
Scheduled
|
Jul 1
| ||
Form 4
| +38.57% | 248 |
—
|
—
| 891 |
Jan 4
| |||
Form 4
|
—
|
0
|
$510.97 | -$609,287.27 | 643 |
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
$495.96 | -$532,476.72 | 643 |
Scheduled
|
Jun 5
| ||
Form 4
| +99.07% | 320 |
—
|
—
| 643 |
Jan 2
| |||
Form 4
|
∞
| 323 |
—
|
—
| 323 |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Royalty Pharma plc (RPRX) Snapshot price: $28.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.45% | 1.4K |
$26.80 | $37,492.92 | 58.45K |
Jun 28
| |||
Form 4
| +19.46% | 9.29K |
—
|
—
| 57.05K |
Jun 7
| |||
Form 4
| +2.67% | 1.24K |
$30.23 | $37,483.09 | 47.76K |
Mar 28
| |||
Form 4
| +3.00% | 1.35K |
$27.71 | $37,492.98 | 46.52K |
Dec 29
| |||
Form 4
| +3.16% | 1.38K |
$27.08 | $37,475.26 | 45.17K |
Sep 29
| |||
Form 4
| +2.84% | 1.21K |
$31.03 | $37,480.98 | 43.78K |
Jun 30
| |||
Form 4
| +22.24% | 7.75K |
—
|
—
| 42.58K |
Jun 23
| |||
Form 4
| +3.11% | 1.05K |
$35.73 | $37,478.25 | 34.83K |
Mar 31
| |||
Form 4
| +2.87% | 943 |
$39.76 | $37,494.91 | 33.78K |
Dec 30
| |||
Form 4
| +2.86% | 913 |
$41.06 | $37,490.43 | 32.84K |
Sep 30
| |||
Form 4
| +2.91% | 903 |
$41.52 | $37,492.83 | 31.93K |
Jun 30
| |||
Form 4
| +25.63% | 6.33K |
—
|
—
| 31.02K |
Jun 24
| |||
Form 4
| +4.06% | 964 |
$38.87 | $37,470.97 | 24.69K |
Mar 31
| |||
Form 4
| +4.21% | 958 |
$39.11 | $37,462.69 | 23.73K |
Dec 31
| |||
Form 4
| +4.55% | 992 |
$37.80 | $37,499.19 | 22.77K |
Sep 30
| |||
Form 4
| +4.17% | 871 |
$43.04 | $37,489.23 | 21.78K |
Jun 30
| |||
Form 4
| +37.71% | 5.73K |
—
|
—
| 20.91K |
Jun 25
| |||
Form 4
| +5.68% | 816 |
$45.90 | $37,457.75 | 15.18K |
Mar 31
| |||
Form 4
| +6.05% | 820 |
$45.69 | $37,464.16 | 14.37K |
Dec 31
| |||
Form 4
| +7.20% | 910 |
$41.17 | $37,468.43 | 13.55K |
Sep 30
| |||
Form 4
|
∞
| 12.64K |
$48.00 | $6,575.86 | 12.64K |
Jun 18 - Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||